A

Akari Therapeutics plc

D
AKTX
USD
0
(0%)
Market Closed
100.000
Volume
-3.4
EPS
-
Div Yield
-1.107779
P/E
39,565,919.50
Market Cap
Today
0.0000%
1 Week
-13.123%
1 Month
-9.066%
6 Months
37.917%
12 Months
-10.054%
Year To Date
10.333%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ATOS
0.03
(2.1127%)
USD
B
BNGO
0.0207
(5.0748%)
USD
C
CBAT
0.057
(6.0445%)
USD
C
CTXR
0.0271
(5.2519%)
USD
D
DNN
0.075
(4.9669%)
USD
E
ENLV
-0.07
(-4.5161%)
USD
E
EVOK
-0.01
(-0.2278%)
USD
G
GNUS
0
(0%)
USD
M
MDRR
0.23
(1.9087%)
USD

Title:
Akari Therapeutics plc

Sector:
Healthcare
Industry:
Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
Do you need help or have a question?
Contact Us